0 Commentaires
0 Parts
254 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Reels
-
Blogs
-
Offres
-
Emplois
-
Connectez-vous pour aimer, partager et commenter!
-
Liquid Biopsy Integration and AI: Projecting the US Biopsy Devices Market forecastThe US Biopsy Devices Market forecast is optimistic, though it faces an interesting technological divergence driven by the emergence of liquid biopsy Technologies. While liquid biopsy provides valuable, non-invasive genetic Market Data, it is not expected to replace tissue biopsy Product Types, but rather complement them, creating a combined diagnostic Standard...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Lung Cancer Liquid Biopsy Market – Industry Trends and Forecast to 2030Regional Overview of Executive Summary Lung Cancer Liquid Biopsy Market by Size and Share CAGR Value Data Bridge Market Research analyses that the lung cancer liquid biopsy market which was USD 0.30 billion in 2022, is expected to reach USD 1.38 billion by 2030, at a CAGR of 21% during the forecast period 2023 to 2030. The market report also contains the drivers and restraints...0 Commentaires 0 Parts 495 Vue 0 Aperçu
-
Biopsy Devices Market: How Are Liquid Biopsy Devices Creating a New Diagnostic Market?Liquid biopsy — the analysis of circulating tumor DNA, circulating tumor cells, exosomes, and other cancer-derived materials in blood samples providing cancer detection, characterization, and monitoring without tissue biopsy — represents the most commercially disruptive innovation in the biopsy devices market, with the Biopsy Devices Market reflecting liquid biopsy as a rapidly...0 Commentaires 0 Parts 648 Vue 0 Aperçu
-
Exosome Diagnostics and Therapeutics Market Drivers in United States: Rising Demand for Liquid Biopsy and Precision MedicineThe Exosome Diagnostics and Therapeutics Market is gaining strong momentum as a next-generation segment within biotechnology and precision medicine, driven by its expanding role in early disease detection, biomarker discovery, and targeted drug delivery systems. Exosomes, which are nanosized extracellular vesicles involved in intercellular communication, are increasingly recognized for...0 Commentaires 0 Parts 427 Vue 0 Aperçu
-
Exosome Therapeutics Market: How Are Exosome Diagnostics Advancing Liquid Biopsy?Engineered exosomes — the genetically or chemically modified exosomes with enhanced targeting, improved cargo loading, or augmented therapeutic properties beyond naturally derived exosomes — represent the next technological evolution addressing the limitations of native exosome therapeutics, with the Exosome Therapeutics Market reflecting engineered exosomes as the primary...0 Commentaires 0 Parts 522 Vue 0 Aperçu
-
Extracellular-Vesicles-Based-Liquid-Biopsy-Market Size, Share, Trends & Forecast Report 2026–2032Global Demand Outlook for Executive Summary Extracellular Vesicles Based Liquid Biopsy Market Size and Share The global extracellular vesicles based liquid biopsy market size was valued at USD 115.09 Million in 2024 and is expected to reach USD 539.41 Million by 2032, at a CAGR of 21.3% during the forecast period In order to make smart decisions about...0 Commentaires 0 Parts 402 Vue 0 Aperçu
-
Global Liquid Biopsy MarketThe latest report titled “Global Liquid Biopsy Market” published by Emergen Research is projected to register a significant growth rate during the forecast period from 2024 to 2034. The Market Intelligence Report provides a complete overview of the Liquid Biopsy market along with details on the competitive landscape and profiles of the key players operating in this business. Our...0 Commentaires 0 Parts 341 Vue 0 Aperçu
-
Liquid Biopsy Market Transforming Cancer Diagnostics and Precision MedicineThe liquid biopsy market is rapidly redefining how cancer is detected, monitored, and treated. Unlike traditional tissue biopsies, liquid biopsy relies on a simple blood sample to identify tumor-derived components such as circulating tumor DNA (ctDNA), RNA, and exosomes. This non-invasive approach is emerging as a cornerstone of precision medicine, enabling clinicians to make...0 Commentaires 0 Parts 462 Vue 0 Aperçu
-
North America Ovarian Cancer Diagnostics Market: Liquid Biopsy Trends and Strategic Forecast 2032"Executive Summary North America Ovarian Cancer Diagnostics Market Size and Share Across Top Segments North America ovarian cancer diagnostics market is expected to grow in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.8% in the forecast period of 2023 to 2030 and is expected to reach USD 5,675.36 million by 2030...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Precision Medicine Market: How Is Liquid Biopsy Advancing Precision Oncology?Liquid biopsy — the analysis of circulating tumor DNA, circulating tumor cells, exosomes, and other cancer-derived materials in blood to detect, characterize, and monitor cancer non-invasively — represents a transformative precision oncology diagnostic approach, with the Precision Medicine Market reflecting liquid biopsy as one of the most commercially significant precision...0 Commentaires 0 Parts 702 Vue 0 Aperçu
-
Targeted DNA/RNA Sequencing Market: How Is Liquid Biopsy Creating the Fastest-Growing Market Segment?Liquid biopsy creating fastest-growing targeted sequencing segment — the commercial development of targeted next-generation sequencing of cell-free DNA (cfDNA) in blood — enabling non-invasive detection of somatic tumor mutations, copy number alterations, and gene fusions from circulating tumor DNA (ctDNA) shed by tumors into the bloodstream — creating a clinical testing...0 Commentaires 0 Parts 48 Vue 0 Aperçu
Plus de résultats
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek